Recurrence of Myopericarditis Following mRNA COVID-19 Vaccination in a Male Adolescent

Tomohiko C. Umei, Yoshikazu Kishino, Keiko Watanabe, Yasuyuki Shiraishi, Taku Inohara, Shinsuke Yuasa, Keiichi Fukuda

Research output: Contribution to journalArticlepeer-review

Abstract

COVID-19 is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The disease has spread worldwide, resulting in health and economic crises. Vaccination against SARS-CoV-2 infection is considered a valid prevention measure to control this pandemic. There have been reports of cases of myopericarditis following mRNA COVID-19 vaccination. We present a case of a 20-year-old man with recurrent myopericarditis following an initial episode of influenza virus–induced myopericarditis and after a second dose of the mRNA-1273 Moderna COVID-19 vaccine. Careful attention should be paid to patients with a history of myocarditis following COVID-19 vaccination.

Original languageEnglish
Pages (from-to)350-352
Number of pages3
JournalCJC Open
Volume4
Issue number3
DOIs
Publication statusPublished - 2022 Mar
Externally publishedYes

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Recurrence of Myopericarditis Following mRNA COVID-19 Vaccination in a Male Adolescent'. Together they form a unique fingerprint.

Cite this